BETRNet: Barrett's Esophagus Translational Research Network

The Barrett’s Esophagus Translational Research Network (BETRNet) is a multi-disciplinary and multi-institutional program that is supported by the National Cancer Institute (NCI). The program was established to achieve a better understanding of esophageal adenocarcinoma biology and its precursor lesion, Barrett’s esophagus, as the foundation for biology-based prevention measures. The overriding goal is to decrease the incidence, morbidity and mortality of a highly lethal cancer in the United States.

The BETRNet program is composed of a single Coordinating Center and multiple Research Centers. The Coordinating Center is located at Vanderbilt University Medical Center while each Research Center represents a consortium of multiple academic institutions. The Research Centers pursue various lines of investigation in their areas of expertise, in addition to working synergistically to support the overarching goals of the BETRNet program. The Coordinating Center provides overall logistical and administrative support to the program as well as developing, maintaining, and managing the BETRNet Patient Registry-Virtual Biorepository (PR-VB).